Showing results (41-50 of 192) with videos related to
Sort By:
Pageof 20
The Open AIDS Journal|October 11, 2012
Piloting a system for behavioral surveillance among heterosexuals at increased risk of HIV in the United StatesElizabeth A Dinenno, Alexandra M Oster, Catlainn Sionean, et al.The Open AIDS Journal|October 11, 2012
Population-based study of risk factors for coronary heart disease among HIV-infected personsJohn Y Oh, Kari Greene, Haiou He, et al.The Open AIDS Journal|October 11, 2012
Repeat Western blot testing after receiving an HIV diagnosis and its association with engagement in careWayne A Duffus, Kristina W Kintziger, James D Heffelfinger, et al.The Open AIDS Journal|June 24, 2025
Can Community Health Workers in Miami Disrupt Disparities among Black People Living with HIV: A Qualitative AnalysisSonjia Kenya, BreAnne Young, Lindsay Richards, et al.The Open AIDS Journal|July 27, 2010
Using a modified intervention mapping approach to develop and refine a single-session motivational intervention for methamphetamine-using men who have sex with menWilliam A Zule, Curtis M Coomes, Rhonda Karg, et al.The Open AIDS Journal|September 28, 2010
HIV Patient Characteristics that Affect Adherence to Exercise Programmes: An Observational StudyAndrea Petróczi, Kim Hawkins, Gareth Jones, et al.The Open AIDS Journal|July 27, 2010
Formative Assessment of ARM-U: A Modular Intervention for Decreasing Risk Behaviors Among HIV-Positive and HIV-Negative Methamphetamine-Using MSMRichard S Garfein, Mitcheal Metzner, Jazmine Cuevas, et al.The Open AIDS Journal|June 3, 2010
A typology of intellectual property management for public health innovation and access: design considerations for policymakersAntony TaubmanThe Open AIDS Journal|July 10, 2015
Factors Supporting and Inhibiting Adherence to HIV Medication Regimen in Women: A Qualitative Analysis of Patient InterviewsOluwakemi Fagbami, Adetokunbo Oluwasanjo, Carrie Fitzpatrick, et al.The Open AIDS Journal|June 7, 2011
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN TrialK U Ulbricht, G M Behrens, M Stoll, et al.Pageof 20